Gilead and LEO Pharma partner to develop programs for inflammatory diseases By Reuters
(Reuters) - Gilead Sciences (NASDAQ:) said on Saturday it has partnered with Denmark's LEO Pharma to develop programs to treat ...
(Reuters) - Gilead Sciences (NASDAQ:) said on Saturday it has partnered with Denmark's LEO Pharma to develop programs to treat ...